MULTICENTER VALIDATION OF THE SENSITIVITY OF THERANOSTIC ALK REARRANGEMENT DETECTION BY FISH ANALYSIS AND PREVALENCE OF ESCAPING MUTATIONS IN CIRCULATING TUMOR CELLS FOR THE NON-INVASIVE MANAGEMENT OF LUNG CANCER PATIENTS: